BACKGROUND: After human leukocyte antigen (HLA) antibody-incompatible transplantation, donor specific and third party HLA antibodies may be found, and their levels fall in a donor-specific manner during the first month. However, these changes have not been previously described in detail. METHODS: Donor-specific HLA antibody (DSA) and third-party HLA antibody (TPA) levels were measured using the microbead method in 44 presensitized patients who had renal transplantation. RESULTS: DSA+TPA fell in the first 4 days after transplantation, and greater falls in DSA indicated absorption by the graft. This occurred for class I (57.8% fall compared with 20.2% for TPA, P<0.0005), HLA DR (63.0% vs. 24.3%, P<0.0004), and for HLA DP/DQ/DRB3-4 (34% vs. 17.5%, P=0.014). Peak DSA levels occurred at a mean of 13 days posttransplant, and they were higher than pretreatment in 25 (57%) patients and lower in 19 (43%) patients (P=ns). The risk of rejection was associated with peak DSA levels; 15 of 25 (60%) patients with DSA at median fluorescence intensity (MFI) more than 7000U experienced rejection, compared with 4 of 7 (57%) patients with peak DSA MFI 2000 to 7000U, and 2 of 12 (17%) patients with peak DSA MFI less than 2000U (P<0.02). DSA levels subsequently fell in a donor specific manner compared to TPA. CONCLUSION: DSA levels may change markedly in the first month after antibody incompatible transplantation, and the risk of rejection was associated with higher pretreatment and peak levels.
BACKGROUND: After human leukocyte antigen (HLA) antibody-incompatible transplantation, donor specific and third party HLA antibodies may be found, and their levels fall in a donor-specific manner during the first month. However, these changes have not been previously described in detail. METHODS:Donor-specific HLA antibody (DSA) and third-party HLA antibody (TPA) levels were measured using the microbead method in 44 presensitized patients who had renal transplantation. RESULTS:DSA+TPA fell in the first 4 days after transplantation, and greater falls in DSA indicated absorption by the graft. This occurred for class I (57.8% fall compared with 20.2% for TPA, P<0.0005), HLA DR (63.0% vs. 24.3%, P<0.0004), and for HLA DP/DQ/DRB3-4 (34% vs. 17.5%, P=0.014). Peak DSA levels occurred at a mean of 13 days posttransplant, and they were higher than pretreatment in 25 (57%) patients and lower in 19 (43%) patients (P=ns). The risk of rejection was associated with peak DSA levels; 15 of 25 (60%) patients with DSA at median fluorescence intensity (MFI) more than 7000U experienced rejection, compared with 4 of 7 (57%) patients with peak DSA MFI 2000 to 7000U, and 2 of 12 (17%) patients with peak DSA MFI less than 2000U (P<0.02). DSA levels subsequently fell in a donor specific manner compared to TPA. CONCLUSION:DSA levels may change markedly in the first month after antibody incompatible transplantation, and the risk of rejection was associated with higher pretreatment and peak levels.
Authors: Carrie A Schinstock; Andrew J Bentall; Byron H Smith; Lynn D Cornell; Matthew Everly; Manish J Gandhi; Mark D Stegall Journal: Am J Transplant Date: 2018-12-15 Impact factor: 8.086
Authors: Laura Pankhurst; Alex Hudson; Lisa Mumford; Michelle Willicombe; Jack Galliford; Olivia Shaw; Raj Thuraisingham; Carmelo Puliatti; David Talbot; Sian Griffin; Nicholas Torpey; Simon Ball; Brendan Clark; David Briggs; Susan V Fuggle; Robert M Higgins Journal: Transplant Direct Date: 2017-06-26
Authors: Renata von Glehn Ponsirenas; Helena B Cazarote; Stanley de Almeida Araújo; David Campos Wanderley; Silvia Shimakura; Joana S Valdameri; Fabiana L C Contieri; Cristina C Q C von Glehn; Michelle F Susin; Vanessa Santos Sotomaior Journal: Transplant Direct Date: 2018-08-22
Authors: Mason Phillpott; Sunil Daga; Rob Higgins; David Lowe; Nithya Krishnan; Daniel Zehnder; David Briggs; Natalia Khovanova Journal: Transpl Int Date: 2022-04-11 Impact factor: 3.842
Authors: Nithya S Krishnan; Daniel Zehnder; Sunil Daga; Dave Lowe; F T Lam; Habib Kashi; Lam Chin Tan; Christopher Imray; Rizwan Hamer; David Briggs; Neil Raymond; Robert M Higgins Journal: PLoS One Date: 2013-07-26 Impact factor: 3.240
Authors: Natasha Khovanova; Sunil Daga; Torgyn Shaikhina; Nithya Krishnan; James Jones; Daniel Zehnder; Daniel Mitchell; Robert Higgins; David Briggs; David Lowe Journal: Transpl Int Date: 2015-09-01 Impact factor: 3.782